Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Case report

A case of native valve endocarditis caused by Burkholderia cepacia without predisposing factors

Authors: Hyun Kyun Ki, Sung Hea Kim, Seong Woo Han, Hae Suk Cheong

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Infective endocarditis is rarely caused by Burkholderia cepacia. This infection is known to occur particularly in immunocompromised hosts, intravenous heroin users, and in patients with prosthetic valve replacement. Most patients with Burkholderia cepacia endocarditis usually need surgical treatment in addition to antimicrobial treatment.

Case Presentation

Here, we report the case of a patient who developed Burkholderia cepacia-induced native valve endocarditis with consequent cerebral involvement without any predisposing factors; she was successfully treated by antimicrobial agents only.

Conclusion

In this report, we also present literature review of relevant cases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tablan OC, Chorba TL, Schidlow DV, White JW, Hardy KA, Gilligan PH, Morgan WM, Carson LA, Martone WJ, Jason JM, Jarvis WR: Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985, 107: 382-387. 10.1016/S0022-3476(85)80511-4.CrossRefPubMed Tablan OC, Chorba TL, Schidlow DV, White JW, Hardy KA, Gilligan PH, Morgan WM, Carson LA, Martone WJ, Jason JM, Jarvis WR: Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985, 107: 382-387. 10.1016/S0022-3476(85)80511-4.CrossRefPubMed
2.
go back to reference Bottone EJ, Douglas SD, Rausen AR, Keusch GT: Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol. 1975, 1: 425-428.PubMedPubMedCentral Bottone EJ, Douglas SD, Rausen AR, Keusch GT: Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol. 1975, 1: 425-428.PubMedPubMedCentral
3.
go back to reference Aggarwal N, Garg S, Pannu HS, Kler TS: Fatal Burkholderia cepacia early prosthetic valve endocarditis: a very rare case and a review of the literature. J Heart Valve Dis. 2005, 14: 271-274.PubMed Aggarwal N, Garg S, Pannu HS, Kler TS: Fatal Burkholderia cepacia early prosthetic valve endocarditis: a very rare case and a review of the literature. J Heart Valve Dis. 2005, 14: 271-274.PubMed
4.
go back to reference Noriega ER, Rubinstein E, Simberkoff MS, Rahal JJ: Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med. 1975, 59: 29-36. 10.1016/0002-9343(75)90318-6.CrossRefPubMed Noriega ER, Rubinstein E, Simberkoff MS, Rahal JJ: Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med. 1975, 59: 29-36. 10.1016/0002-9343(75)90318-6.CrossRefPubMed
6.
go back to reference Welch DF, Muszynski MJ, Pai CH, Marcon MJ, Hribar MM, Gilligan PH, Matsen JM, Ahlin PA, Hilman BC, Chartrand SA: Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol. 1987, 25: 1730-1734.PubMedPubMedCentral Welch DF, Muszynski MJ, Pai CH, Marcon MJ, Hribar MM, Gilligan PH, Matsen JM, Ahlin PA, Hilman BC, Chartrand SA: Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis. J Clin Microbiol. 1987, 25: 1730-1734.PubMedPubMedCentral
7.
go back to reference Goldmann DA, Klinger JD: Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr. 1986, 108: 806-812. 10.1016/S0022-3476(86)80749-1.CrossRefPubMed Goldmann DA, Klinger JD: Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr. 1986, 108: 806-812. 10.1016/S0022-3476(86)80749-1.CrossRefPubMed
8.
go back to reference Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H: Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984, 104: 206-210. 10.1016/S0022-3476(84)80993-2.CrossRefPubMed Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H: Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984, 104: 206-210. 10.1016/S0022-3476(84)80993-2.CrossRefPubMed
9.
go back to reference van Pelt C, Verduin CM, Goessens WH, Vos MC, Tummler B, Segonds C, Reubsaet F, Verbrugh H, van Belkum A: Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol. 1999, 37: 2158-2164.PubMedPubMedCentral van Pelt C, Verduin CM, Goessens WH, Vos MC, Tummler B, Segonds C, Reubsaet F, Verbrugh H, van Belkum A: Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol. 1999, 37: 2158-2164.PubMedPubMedCentral
10.
go back to reference Neu HC, Garvey GJ, Beach MP: Successful treatment of Pseudomonas cepacia endocarditis in a heroin addict with trimethoprim-sulfamethoxazole. J Infect Dis. 1973, 128 (Suppl): 768-770. 10.1093/infdis/128.Supplement_3.S768.CrossRefPubMed Neu HC, Garvey GJ, Beach MP: Successful treatment of Pseudomonas cepacia endocarditis in a heroin addict with trimethoprim-sulfamethoxazole. J Infect Dis. 1973, 128 (Suppl): 768-770. 10.1093/infdis/128.Supplement_3.S768.CrossRefPubMed
11.
go back to reference Hamilton J, Burch W, Grimmett G, Orme K, Brewer D, Frost R, Fulkerson C: Successful treatment of Pseudomonas cepacia endocarditis with trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1973, 4: 551-554.CrossRefPubMedPubMedCentral Hamilton J, Burch W, Grimmett G, Orme K, Brewer D, Frost R, Fulkerson C: Successful treatment of Pseudomonas cepacia endocarditis with trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1973, 4: 551-554.CrossRefPubMedPubMedCentral
12.
go back to reference Rahal JJ, Simberkoff MS, Hyams PJ: Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B. J Infect Dis. 1973, 128 (Suppl): 762-767. 10.1093/infdis/128.Supplement_3.S762.CrossRefPubMed Rahal JJ, Simberkoff MS, Hyams PJ: Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B. J Infect Dis. 1973, 128 (Suppl): 762-767. 10.1093/infdis/128.Supplement_3.S762.CrossRefPubMed
13.
go back to reference Mandell IN, Feiner HD, Price NM, Simberkoff M: Pseudomonas cepacia endocarditis and ecthyma gangrenosum. Arch Dermatol. 1977, 113: 199-202. 10.1001/archderm.113.2.199.CrossRefPubMed Mandell IN, Feiner HD, Price NM, Simberkoff M: Pseudomonas cepacia endocarditis and ecthyma gangrenosum. Arch Dermatol. 1977, 113: 199-202. 10.1001/archderm.113.2.199.CrossRefPubMed
14.
go back to reference Mann T, Ben-David D, Zlotkin A, Shachar D, Keller N, Toren A, Nagler A, Smollan G, Barzilai A, Rahav G: An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients. Infection. 2010, 38: 187-194. 10.1007/s15010-010-0017-0.CrossRefPubMed Mann T, Ben-David D, Zlotkin A, Shachar D, Keller N, Toren A, Nagler A, Smollan G, Barzilai A, Rahav G: An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients. Infection. 2010, 38: 187-194. 10.1007/s15010-010-0017-0.CrossRefPubMed
15.
go back to reference Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J: Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis. 2000, 19: 320-323. 10.1007/s100960050485.CrossRefPubMed Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J: Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumours. Eur J Clin Microbiol Infect Dis. 2000, 19: 320-323. 10.1007/s100960050485.CrossRefPubMed
16.
go back to reference Kaitwatcharachai C, Silpapojakul K, Jitsurong S, Kalnauwakul S: An outbreak of Burkholderia cepacia bacteremia in hemodialysis patients: an epidemiologic and molecular study. Am J Kidney Dis. 2000, 36: 199-204. 10.1053/ajkd.2000.8295.CrossRefPubMed Kaitwatcharachai C, Silpapojakul K, Jitsurong S, Kalnauwakul S: An outbreak of Burkholderia cepacia bacteremia in hemodialysis patients: an epidemiologic and molecular study. Am J Kidney Dis. 2000, 36: 199-204. 10.1053/ajkd.2000.8295.CrossRefPubMed
Metadata
Title
A case of native valve endocarditis caused by Burkholderia cepacia without predisposing factors
Authors
Hyun Kyun Ki
Sung Hea Kim
Seong Woo Han
Hae Suk Cheong
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-114

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.